Drug General Information
Drug ID
D0M4JP
Former ID
DNC011074
Drug Name
KNI-10759
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531036]
Structure
Download
2D MOL

3D MOL

Formula
C43H59N5O6S
Canonical SMILES
CCN(CC)CCN(CC)C1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C<br />(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C
InChI
1S/C43H59N5O6S/c1-8-46(9-2)20-21-47(10-3)32-22-28(4)39(29(5)23-32)54-26-36(50)44-34(24-30-16-12-11-13-17-30)38(51)42(53)48-27-55-43(6,7)40(48)41(52)45-37-33-19-15-14-18-31(33)25-35(37)49/h11-19,22-23,34-35,37-38,40,49,51H,8-10,20-21,24-27H2,1-7H3,(H,44,50)(H,45,52)/t34-,35+,37-,38-,40+/m0/s1
InChIKey
FEJYRCRZYXAOJX-MQKWNYJDSA-N
PubChem Compound ID
Target and Pathway
Target(s) Plasmepsin 2 Target Info Inhibitor [531036]
References
Ref 531036Bioorg Med Chem Lett. 2010 Aug 15;20(16):4836-9. Epub 2010 Jun 25.Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
Ref 531036Bioorg Med Chem Lett. 2010 Aug 15;20(16):4836-9. Epub 2010 Jun 25.Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.